Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEPX HIV prevention study
ACTRN12616001215415Phase 4Recruiting
- Sponsor
- Alfred Health
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of emtricitabine and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Alfred Health. Primary endpoint: Number of new HIV infections in Victoria. Started Jul 2016; status: recruiting.
02
Drugs
emtricitabinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ACTRN12616001215415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001215415.